Target intelligence / Profile preview

Influenza A Hemagglutinin Protein (HA)

Target
HA
Molecular classification
Glycoprotein, Type I transmembrane protein, Viral protein
01

Overview

Influenza A hemagglutinin (HA) is a homotrimeric glycoprotein found on the surface of influenza A viruses. It is a type I transmembrane protein and serves as the primary antigenic determinant of the virus, playing essential roles in both viral entry into host cells and immune recognition. HA exists as a trimer, with each monomer composed of two subunits: HA1 and HA2, generated by proteolytic cleavage of an initial precursor polypeptide (HA0). The globular head binds to sialic acid-containing receptors on host cell surfaces and the stem domain anchors the protein to the viral membrane and mediates membrane fusion during viral entry. Antigenic variation within its structure underlies seasonal flu epidemics/pandemics. Stabilization of prefusion forms of HA has become a key strategy for improving vaccine efficacy.

Other names
HemagglutininHA proteinInfluenza hemagglutinin
02

Mechanism of action

NAbs block receptor binding or membrane fusion. Vaccines elicit antibody response against HA.

03

Biological functions

Receptor bindingMembrane fusionHost cell entryImmune recognitionViral attachment
04

Disease associations

InfectionInfluenzaViral pathogenesis
05

Safety considerations

Antigenic variation (drift/shift)Evasion of pre-existing immunityPotential for pandemic emergenceOff-target immune responses
06

Interacting drugs

NAbs (Neutralizing Antibodies)

1 more in the full profile.

07

Biomarkers

HA antibody titers (for vaccine efficacy)HA sequence variations (for strain typing and resistance monitoring)

Beyond the preview

Go deeper on Influenza A Hemagglutinin Protein (HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A Hemagglutinin Protein (HA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call